Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial

Overview of attention for article published in Journal of Clinical Oncology, June 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 6 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 36 X users

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page
guideline: 4 clinical guideline sources

Readers on

mendeley: 245 Mendeley

So far, Altmetric has seen 39 X posts from 36 X users, with an upper bound of 239,609 followers.

#5 Calidad de vida 🙋🙋🏻‍♀️ Uno de los parámetros en los que el tratamiento con Lu177 tuvo un mayor impacto en calidad de vida de los pacientes fue la mejoría de las diarreas. https://t.co/wEtvWii9wK https://t.co/auehaFFznt

@sethmhardy @BradleyGirod @VPrasadMDMPH (A) Global health status; (B) physical functioning; (C) role functioning; (D) fatigue https://t.co/q5Q9cJRSF4 https://t.co/CuxccL2AQq

RT @SEMNIMoficial: Mejora de la calidad de vida mediante procedimientos terapéuticos de medicina nuclear con 177Lu-DOTATATE https://t.co/AA…

RT @Nuclear_HUMS: Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in t…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 35 additional X posts.